[Treatment of secretory otitis media].
Blood serum of 38 patients with otitis media (14 men and 24 women), aged 16 to 55 years, was examined immunologically. The patients were subdivided into two groups that received identical traditional therapy. However the Group 2 patients were also given per os 0.5 g sodium nucleinate 3 times a day for 10 days. Before and after treatment all the patients underwent immunological tests which included measurements of T- and B-lymphocytes, T-helpers and T-suppressors as well as immunoglobulins M, A, G and complement. It was demonstrated that sodium nucleinate exerted beneficial clinical and immunological effects.
Iarlykov
S A
SA
Zemskov
A M
AM
Poliakova
S D
SD
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D003165:Complement System Proteins / Q000032:analysis; D004322:Drainage; D004432:Ear, Middle / Q000601:surgery; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D010034:Otitis Media with Effusion / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007136:Immunoglobulins; D009696:Nucleic Acids; D003165:Complement System Proteins; C013683:sodium nucleinate
Lechenie sekretornykh srednikh otitov.